Monthly Archives: July 2012

LinkedIn/’RateStars’ Phishing Scam

LinkedIn members are receiving requests for ‘rating’ for connections that begin with ‘…needs your help.’ During the response process, the sender phishes for log-in information, and even if you terminate the exchange there, as I did, they receive and utilize … Continue reading

Posted in Uncategorized | Tagged | 19 Comments

Putting Bapi in Perspective

The topline results of the first bapineuzumab Phase III to report came out today, and to the surprise of no one that we know, they were negative. This trial was in APOE4 carriers, the next Phase III trial to reportĀ  … Continue reading

Posted in Big Pharma, BioFollies | Tagged , , , , , | 1 Comment

Viva EnVivo: EVP-6124 in Alzheimer’s

NIR has been waiting for the results of two particular clinical trials to be publicly released, since these programs have achieved the kind of success that should start to catalyze a shift in sentiment about prospects for CNS drug development. … Continue reading

Posted in Biotech, Science | Tagged , , , , | Leave a comment

Et tu, Dr. Drew?

Bearing witness to the commercial maneuvers of the Pharma Industry has never been a task suitable for anyone prone to queasiness. The latest reminder of the moral banana peel upon which Big Pharma slips and slides is GSK‘s $3 billion … Continue reading

Posted in Big Pharma, BioFollies | Tagged , , , | Leave a comment

Weather Update

The National Weather Service reports that there are some breaks in the thick layer of clouds and fog which has covered the CNS space for much of the past year. While there are not yet clear signs of a summer … Continue reading

Posted in Big Pharma, Biotech, Science | Tagged , , , , | Leave a comment